Rapid genetic testing can prevent hearing loss in newborns treated for sepsis

(European Society of Human Genetics) More than a million neonatal deaths worldwide each year are estimated to be due to sepsis. Many patients receive antibiotic therapy during their hospital stay, but babies with a specific genetic change can suffer irreversible hearing loss as a result. Now, a rapid test for distinguishing those infants who will have this adverse reaction to gentamicin has been developed.
Source: EurekAlert! - Infectious and Emerging Diseases - Category: Infectious Diseases Source Type: news